Tevogen Bio
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $396 | $0 | $0 |
Gross Profit | -290 | -105 | -101 | |
EBITDA | -5,417 | -10,356 | -5,652 | |
EBIT | -5,444 | -10,461 | -5,871 | |
Net Income | -5,503 | -10,367 | -9,444 | -5,884 |
Net Change In Cash | 0 | 396 | 0 | 0 |
Free Cash Flow | -3,189 | -3,308 | -3,047 | -3,804 |
Cash | 685 | 1,974 | 1,282 | 2,330 |
Basic Shares | 184,307 | 161,407 | 177,991 | 170,174 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -403 | |||
EBITDA | -13,139 | -2,273 | -953 | -28 |
EBIT | -13,543 | -2,471 | -1,183 | -38 |
Net Income | -13,727 | -67 | 4,408 | -15,596 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -11,998 | -8,304 | -694 | -5,384 |
Cash | 1,282 | 8 | 129 | 7,119 |
Basic Shares | 146,672 | 165,421 | 119,999 | 47,933 |
